zidovudine has been researched along with glucuronic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boase, S; Miners, JO | 1 |
Choonara, YE; Danckwerts, MP; du Toit, LC; Harilall, SL; Iyuke, SE; Kumar, P; Modi, G; Pillay, V; Tomar, LK; Tyagi, C | 1 |
George, A; Jose, J; Joshy, KS; Kalarikkal, N; Pothen, LA; Thomas, S | 1 |
Joshy, KS; Laly, AP; Nandakumar, K; Sabu, T; Snigdha, S; Susan, MA | 1 |
4 other study(ies) available for zidovudine and glucuronic acid
Article | Year |
---|---|
In vitro-in vivo correlations for drugs eliminated by glucuronidation: investigations with the model substrate zidovudine.
Topics: Anti-HIV Agents; Biotransformation; Glucuronates; Glucuronic Acid; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Microsomes, Liver; Zidovudine | 2002 |
Design and pharmaceutical evaluation of a nano-enabled crosslinked multipolymeric scaffold for prolonged intracranial release of Zidovudine.
Topics: Alginates; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Carriers; Glucuronic Acid; Hexuronic Acids; Hydrochloric Acid; Hydrogen-Ion Concentration; Nanoparticles; Particle Size; Polymers; Surface Properties; Technology, Pharmaceutical; Zidovudine | 2013 |
Novel dendritic structure of alginate hybrid nanoparticles for effective anti-viral drug delivery.
Topics: Alginates; Antiviral Agents; Cell Line, Tumor; Cell Survival; Dendrimers; Drug Carriers; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Humans; Nanoparticles; Polyethylene Glycols; Zidovudine | 2017 |
Encapsulation of zidovudine in PF-68 coated alginate conjugate nanoparticles for anti-HIV drug delivery.
Topics: Alginates; Amides; Anti-HIV Agents; Chitosan; Drug Carriers; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; HIV; HIV Infections; Humans; Nanoparticles; Zidovudine | 2018 |